logo
Select company
Select metric
$ -36.47MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
16
Sector
40
Industry
55
History
71
$ 1.58Close
$ 0.26 - $ 1.84 52-Week Range
Ticker Information

Ticker

OVID

Company Name

OVID THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

OVID THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

OVID - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 1.71M$ -38.18M$ -36.47M
3/31/2025$ 1.74M$ -24.97M$ -23.24M
12/31/2024$ 1.71M$ -26.43M$ -24.72M
9/30/2024$ 1.67M$ -32.5M$ -30.83M
6/30/2024$ 1.63M$ -29.75M$ -28.12M
3/31/2024$ 1.6M$ -50.68M$ -49.08M
12/31/2023$ 1.6M$ -52.34M$ -50.74M
9/30/2023$ 1.64M$ -48.52M$ -46.89M
6/30/2023$ 1.65M$ -49.24M$ -47.59M
3/31/2023$ 1.71M$ -51.42M$ -49.71M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • OVID THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -75.7M.
  • Over the past 5 years, OVID THERAPEUTICS INC's average EBITDA has been $ -15.39M.
  • The median EBITDA for OVID THERAPEUTICS INC during this period was $ -47.24M
  • OVID THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ 128.75M.
  • The lowest EBITDA recorded by OVID THERAPEUTICS INC in the same timeframe $ -80.73M

OVID THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
VERU : VERU INC $ -31.9MCUE : CUE BIOPHARMA INC $ -36.06MPSTV : PLUS THERAPEUTICS INC $ -14.57MCBUS : CIBUS INC $ -234.61MTCRX : TSCAN THERAPEUTICS INC $ -130.55MCRVO : CERVOMED INC $ -22.61MALGS : ALIGOS THERAPEUTICS INC $ -58.76MPYXS : PYXIS ONCOLOGY INC $ -95.04MNTRB : NUTRIBAND INC $ -9.95MARMP : ARMATA PHARMACEUTICALS INC $ -10.66M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for OVID THERAPEUTICS INC is calculated as follows: EBIT [ $ -75.98M ] + DepAmor [ $ 277.61K ]
(=) EBITDA [ $ -75.7M ]

OVID - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -80.73M

Minimum

Dec 31, 2020

$ 128.75M

Maximum

Sep 30, 2021

$ -15.39M

Average

$ -47.24M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M